drugset / Trial / NCT04249583
Treatment of Moderate to Severe Glabellar Lines
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe GL.
Timeline
- Start
- 2020-02-10
- Primary completion
- 2020-08-07
- Completion
- 2021-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.